These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16000445)

  • 1. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
    Söderlund-Strand A; Rymark P; Andersson P; Dillner J; Dillner L
    J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.
    Huang SL; Chao A; Hsueh S; Chao FY; Huang CC; Yang JE; Lin CY; Yan CC; Chou HH; Huang KG; Huang HJ; Wu TI; Tseng MJ; Qiu JT; Lin CT; Chang TC; Lai CH
    J Clin Microbiol; 2006 May; 44(5):1733-9. PubMed ID: 16672400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.
    Zielinski GD; Rozendaal L; Voorhorst FJ; Berkhof J; Snijders PJ; Risse EJ; Runsink AP; de Schipper FA; Meijer CJ
    Gynecol Oncol; 2003 Oct; 91(1):67-73. PubMed ID: 14529664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results.
    Venturoli S; Cricca M; Bonvicini F; Giosa F; Pulvirenti FR; Galli C; Musiani M; Zerbini M
    J Clin Virol; 2002 Aug; 25(2):177-85. PubMed ID: 12367652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus testing with a liquid-based system: feasibility and comparison with reference diagnoses.
    Bergeron C; Cas F; Fagnani F; Didailler-Lambert F; Poveda JD
    Acta Cytol; 2006; 50(1):16-22. PubMed ID: 16514835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
    Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
    Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
    Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation.
    Lonky NM; Felix JC; Naidu YM; Wolde-Tsadik G
    Obstet Gynecol; 2003 Mar; 101(3):481-9. PubMed ID: 12636951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing in women with mild cytologic atypia.
    Bergeron C; Jeannel D; Poveda J; Cassonnet P; Orth G
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):821-7. PubMed ID: 10831974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved rate of high-grade cervical intraepithelial neoplasia detection in human papillomavirus DNA hybrid capture testing.
    Proca DM; Williams JD; Rofagha S; Tranovich VL; Keyhani-Rofagha S
    Anal Quant Cytol Histol; 2007 Aug; 29(4):264-70. PubMed ID: 17879635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results.
    Mo LZ; Monnier-Benoit S; Kantelip B; Petitjean A; Riethmuller D; Prétet JL; Mougin C
    J Clin Virol; 2008 Feb; 41(2):104-10. PubMed ID: 18036888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
    [No Abstract]   [Full Text] [Related]  

  • 19. Consensus polymerase chain reaction and enzyme-linked immunosorbent assay for human papillomavirus detection and typing in cervical specimens.
    Merkelbach-Bruse S; Jakob C; Tietze L; Schröder W; Rath W; Füzesi L
    Diagn Mol Pathol; 1999 Mar; 8(1):32-8. PubMed ID: 10408791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.